A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Name: A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Published: 2013
License: Public Domain

Janssen Research & Development, LLC · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

ovarian neoplasms, peritoneal neoplasms, fallopian tube neoplasms, advanced-relapsed epithelial ovarian cancer, advanced-relapsed primary peritoneal cancer, advanced-relapsed fallopian tube cancer, trabectedin, yondelis, doxil, caelyx, platinum sensitive, tthird-line

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 853703
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.